跳至主要内容
临床试验/JPRN-UMIN000016681
JPRN-UMIN000016681已完成未知

Effect of Goreisan in preventing or reducing diarrhea in patients receiving concurrent chemoradiotherapy for cervical cancer - Effect of Goreisan in preventing or reducing chemoradiation-induced diarrhea

Chiba University Hospital0 个研究点目标入组 40 人开始时间: 2015年3月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1) Inflammatory bowel disease such as Crohn disease and ulcerative colitis 2) Severe hepatic dysfunction (aspartate aminotransferase or alanine aminotransferase >=100 U/L) 3) Severe renal dysfunction (serum creatinine >=1.5 mg/dL or blood urea nitrogen >=25 mg/dL) 4) Mental illness that may require the administration of antipsychotics, and dementia 5) Current use of other oriental medicine 6) A history of the hypersensitivity that is serious for the study medicine, or drug allergy 7) Any case that the chief physician judges to be inadequate.

研究者

相似试验

Effect of Goreisan in preventing or reducing... | 临床试验